Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

66 trials with published results (7%)

Research Maturity

501 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.8%

58 terminated out of 1004 trials

Success Rate

89.6%

+3.1% vs benchmark

Late-Stage Pipeline

11%

108 trials in Phase 3/4

Results Transparency

13%

66 of 501 completed with results

Key Signals

66 with results90% success58 terminated

Data Visualizations

Phase Distribution

495Total
Not Applicable (276)
Early P 1 (7)
P 1 (25)
P 2 (79)
P 3 (38)
P 4 (70)

Trial Status

Completed501
Unknown167
Recruiting128
Not Yet Recruiting69
Terminated58
Withdrawn40

Trial Success Rate

89.6%

Benchmark: 86.5%

Based on 501 completed trials

Clinical Trials (1004)

Showing 20 of 20 trials
NCT07212595Phase 2Not Yet RecruitingPrimary

Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy

NCT07654010CompletedPrimary

The Value of Partial Arterial Carbon Dioxide Pressure - End-Tidal Carbon Dioxide Gradient Courses in Predicting Acute Renal Injury in Critically Ill Patients on Mechanical Ventilation: A Novel Hemodynamic Marker?

NCT06535945Phase 4Recruiting

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

NCT07653321Enrolling By InvitationPrimary

Acute Kidney Injury in Critically Ill Patients

NCT05033652Not ApplicableCompletedPrimary

Impact on Mortality of Screening for Kidney Disease Associated With a Specialized Intervention During Hospitalization in a Territorial Hospital Trust

NCT07643597Not Yet RecruitingPrimary

Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients

NCT03547414RecruitingPrimary

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

NCT03628300Completed

Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors

NCT07630220Not ApplicableNot Yet RecruitingPrimary

The Effect of Standard vs. Shorter Filter Lifespan During Continuous Renal Replacement Therapy

NCT04010630Not ApplicableCompleted

Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU

NCT05879432Phase 2RecruitingPrimary

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

NCT04592744Phase 4Active Not Recruiting

Angiotensin 2 for AKI After OLT

NCT04633889Phase 2Active Not RecruitingPrimary

Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury

NCT07637435Not ApplicableCompletedPrimary

Role of Vascular Endothelial Markers in Predicting Renal Prognosis and Mortality in Patients Undergoing HD-AKI

NCT04864847CompletedPrimary

Clinical Validation of the RENISCHEM L-FABP POC Assay

NCT07132619CompletedPrimary

AKI After Pulmonary Endarterectomy

NCT05806645Not ApplicableRecruitingPrimary

UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

NCT07635160Recruiting

Assessment of Renal Perfusion Using Ultrasound and Near-Infrared Spectroscopy in Patients Undergoing Minimally Invasive Abdominal Surgery

NCT07636083Not Yet Recruiting

Acute Kidney Injury in Upper GI Bleeding Patients

NCT05900284Phase 2Completed

Safety and Feasibility of Metformin for Sepsis Induced AKI

Scroll to load more

Research Network

Activity Timeline